Top Small Cap Stocks To Own Right Now

Small cap generic pharmaceutical stock Lannett Company, Inc (NYSE: LCI) is the third most shorted stock on the NYSE with short interest of 52.86% according to Highshortinterest.com. Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications and therapeutic areas. The Company believe that its ability to select viable products for development, efficiently develop such products (including obtaining any applicable regulatory approvals), vertically integrate itself into certain specialty markets and achieve economies in production are all critical for its success in the generic pharmaceutical industry in which it operates.

A technical chart for Lannett Company shows shares recently bouncing off a key support level and largely moving up over the past several trading days with shares rising 3.76% to $20.70 on Monday:

Top Small Cap Stocks To Own Right Now: ATA Inc.(ATAI)

Advisors’ Opinion:

  • [By Paul Ausick]

    ATA Inc. (NASDAQ: ATAI) traded down about 14% Monday to set a new 52-week low of $0.82, based on revalued shares that closed at $0.72 on Friday but traded up about 250% on Monday at $2.53. Volume was more than 200 times the daily average of around 42,000. You’re on your own here to figure this one out.

Top Small Cap Stocks To Own Right Now: Petroquest Energy Inc(PQ)

Advisors’ Opinion:

  • [By Ethan Ryder]

    News headlines about Petroquest Energy (NYSE:PQ) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Petroquest Energy earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave news stories about the energy company an impact score of 47.638327846877 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Top Small Cap Stocks To Own Right Now: FuelCell Energy Inc.(FCEL)

Advisors’ Opinion:

  • [By Shane Hupp]

    FuelCell Energy (NASDAQ: FCEL) is one of 25 public companies in the “Miscellaneous electrical machinery, equipment, & supplies” industry, but how does it contrast to its peers? We will compare FuelCell Energy to related companies based on the strength of its risk, dividends, earnings, valuation, profitability, analyst recommendations and institutional ownership.

  • [By Shane Hupp]

    FuelCell Energy Inc (NASDAQ:FCEL) shares traded up 5.8% on Friday . The stock traded as high as $1.49 and last traded at $1.45. 12,581,855 shares traded hands during trading, an increase of 983% from the average session volume of 1,161,380 shares. The stock had previously closed at $1.37.

  • [By Paul Ausick]

    FuelCell Energy Inc. (NASDAQ: FCEL) posted a decrease of 4% in short interest during the period. Some 7.42 million shares were short as of June 15. The stock closed at $1.37 on Tuesday, down about 1.4% for the day, in a 52-week range of $1.18 to $2.49. Shares traded down more than 10% in the short interest period, and days to cover dropped from 17 to six.

  • [By Chris Lange]

    FuelCell Energy Inc. (NASDAQ: FCEL) is due to share its most recent quarterly results first thing Thursday. Analysts are looking for a net loss of $0.19 per share and revenue of $11.32 million. Its shares traded at $1.17 on Friday’s close, in a 52-week range of $1.00 to $2.49. The consensus price target is $3.15.

  • [By Scott Levine]

    One of the notable advantages of fuel cells is that they produce very little pollution. FuelCell Energy (NASDAQ:FCEL), however, believes that it could leverage the power of fuel cells in another way to fight pollution — by capturing it. Partnering with ExxonMobil and Southern Company, FuelCell Energy is developing a carbon-capture solution to be used at gas-fired power plants. The pilot project is under development at a power plant in Alabama.

  • [By Paul Ausick]

    FuelCell Energy Inc. (NASDAQ: FCEL) posted a dip of 4.7% in short interest during the short interest period. Some 9.92 million shares were short as of August 15. The stock closed at $1.15 on Friday, up about 0.9% for the day, in a 52-week range of $1.00 to $2.49. Shares traded down about 20.7% in the two-week period, and days to cover were unchanged at nine.

Top Small Cap Stocks To Own Right Now: Achillion Pharmaceuticals Inc.(ACHN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.

  • [By Keith Speights]

    Skeptics might deride a comparison of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) as an exercise in finding the biggest loser. Both companies continue to post huge net losses every quarter, and their stocks are down by at least 30% over the last 12 months.

  • [By Stephan Byrd]

    Achillion Pharmaceuticals (NASDAQ:ACHN) has been given an average recommendation of “Hold” by the nine brokerages that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $5.20.

Top Small Cap Stocks To Own Right Now: China Metro-Rural Holdings Limited(CNR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Canadian National Railway (NYSE:CNI) (TSE:CNR) – Analysts at Seaport Global Securities issued their Q1 2019 EPS estimates for shares of Canadian National Railway in a research note issued to investors on Wednesday, January 30th. Seaport Global Securities analyst M. Levin expects that the transportation company will earn $0.96 per share for the quarter. Seaport Global Securities also issued estimates for Canadian National Railway’s Q2 2019 earnings at $1.26 EPS, Q3 2019 earnings at $1.27 EPS and Q4 2019 earnings at $1.26 EPS.

  • [By Shane Hupp]

    Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp cut its position in Canadian National Railway (NYSE:CNI) (TSE:CNR) by 21.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,956,400 shares of the transportation company’s stock after selling 522,300 shares during the period. Canadian National Railway accounts for about 1.7% of Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp’s investment portfolio, making the stock its 7th biggest position. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp owned 0.27% of Canadian National Railway worth $184,215,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Shares of Canadian National Railway (NYSE:CNI) (TSE:CNR) have been assigned a consensus recommendation of “Buy” from the twenty-two ratings firms that are currently covering the firm, Marketbeat.com reports. Eleven research analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $91.71.

Leave a Reply

Your email address will not be published. Required fields are marked *